Cargando…

Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors

BACKGROUND: Pituitary neuroendocrine tumors (PitNETs), which originate from the pituitary gland, account for 10%–15% of all intracranial neoplasms. Recent studies have indicated that enhancer RNAs (eRNAs) exert regulatory effects on tumor growth. However, the mechanisms underlying the eRNA-mediated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liangbo, Wei, Chenlu, Wang, Yu, Huang, Ning, Zhang, Tao, Dai, Yuting, Xue, Li, Lin, Shaojian, Wu, Zhe Bao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393250/ https://www.ncbi.nlm.nih.gov/pubmed/37534217 http://dx.doi.org/10.3389/fendo.2023.1149997

Ejemplares similares

Hydroxychloroquine overcomes cabergoline resistance in a patient with Lactotroph Pituitary neuroendocrine tumor: a case report
por: Lin, Shaojian, et al.
Publicado: (2022)

Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
por: Han, Changxi, et al.
Publicado: (2021)

Pseudocapsule and pseudocapsule-based extracapsular resection in pituitary neuroendocrine tumors
por: Wang, Xiao Bin, et al.
Publicado: (2022)

Epithelial-Mesenchymal Transition Is a Critical Step in Tumorgenesis of Pancreatic Neuroendocrine Tumors
por: Fendrich, Volker, et al.
Publicado: (2012)

Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment
por: Wu, Jiangping, et al.
Publicado: (2023)

Pituitary Metastasis of Lung Neuroendocrine Carcinoma Mimicking Pituitary Adenoma:Case Report and Literature Review
por: Liu, Xiaohai, et al.
Publicado: (2021)

Exosomal RNAs in the development and treatment of pituitary adenomas
por: Chang, Mengqi, et al.
Publicado: (2023)

Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor
por: Luo, Peiqiong, et al.
Publicado: (2020)

LBODP077 The Therapeutic Potential Of Targeting Histone Deacetylase For Pituitary Neuroendocrine Tumors By High-throughout Drug Screening
por: Wu, Zhe Bao, et al.
Publicado: (2022)

Case Report: Micro-RNAs in Plasma From Bilateral Inferior Petrosal Sinus Sampling and Peripheral Blood From Corticotroph Pituitary Neuroendocrine Tumors
por: Niedra, Helvijs, et al.
Publicado: (2022)

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain
por: Lamas, Cristina, et al.
Publicado: (2023)

Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
por: Tomasik, Agnieszka, et al.
Publicado: (2022)

Expression of EGFR in Pituitary Corticotroph Adenomas and Its Relationship With Tumor Behavior
por: Liu, Xiaohai, et al.
Publicado: (2019)

Sellar Glomus Tumor Misdiagnosed as Pituitary Adenoma: A Case Report and Review of the Literature
por: Cheng, Yijun, et al.
Publicado: (2022)

The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction
por: Xie, Qinying, et al.
Publicado: (2022)

SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth via Targeting VEGFA
por: Wang, Xiaoyu, et al.
Publicado: (2020)

Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis
por: Wang, Hongdan, et al.
Publicado: (2023)

Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors
por: Wen, Siqi, et al.
Publicado: (2021)

Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors
por: Gil, Joan, et al.
Publicado: (2023)

Identification of Neuroendocrine Stress Response-Related Circulating MicroRNAs as Biomarkers for Type 2 Diabetes Mellitus and Insulin Resistance
por: Liang, Ying-Zhi, et al.
Publicado: (2018)

THU083 Disulfiram Mediated Anti-tumor Effect In Pituitary Neuroendocrine Tumors By Inducing Cuproptosis
por: Huang, Ning, et al.
Publicado: (2023)

The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020)

The Treatment of Refractory Pituitary Adenomas
por: Dai, Congxin, et al.
Publicado: (2019)

Genetic and Epigenetic Causes of Pituitary Adenomas
por: Chang, Mengqi, et al.
Publicado: (2021)

How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies
por: Dai, Congxin, et al.
Publicado: (2021)

A Case of an Immature PIT1-Lineage Pituitary Neuroendocrine Tumor of the Nasopharynx
por: Peters, Jessica, et al.
Publicado: (2023)

Visual analytics identifies key miRNAs for differentiating peripancreatic paraganglioma and pancreatic neuroendocrine tumors
por: Enguita, Jose María, et al.
Publicado: (2023)

A potential impact of SARS-CoV-2 on pituitary glands and pituitary neuroendocrine tumors
por: Gu, Wei Ting, et al.
Publicado: (2021)

Osteosarcoma Cell-Derived Exosomal miR-1307 Promotes Tumorgenesis via Targeting AGAP1
por: Han, Fei, et al.
Publicado: (2021)

Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment
por: Luo, Shuaiwu, et al.
Publicado: (2023)

Antibodies Against Hypothalamus and Pituitary Gland in Childhood-Onset Brain Tumors and Pituitary Dysfunction
por: Patti, Giuseppa, et al.
Publicado: (2020)

The Stem Cell Connection of Pituitary Tumors
por: Vankelecom, Hugo, et al.
Publicado: (2017)

Transcriptome-Wide Identification of Preferentially Expressed Genes in the Hypothalamus and Pituitary Gland
por: St-Amand, Jonny, et al.
Publicado: (2012)

Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors
por: Nakano-Tateno, Tae, et al.
Publicado: (2021)

Ovarian Aging: Role of Pituitary-Ovarian Axis Hormones and ncRNAs in Regulating Ovarian Mitochondrial Activity
por: Colella, Marco, et al.
Publicado: (2021)

TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC
por: Tang, Bufu, et al.
Publicado: (2023)

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model
por: Zahavi, Tamar, et al.
Publicado: (2015)

Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors—Two Sides of the Same Coin
por: Butz, Henriett
Publicado: (2022)

Editorial: Systems Biological Aspects of Pituitary Tumors
por: Zhan, Xianquan, et al.
Publicado: (2016)

Editorial: Resistance to Medical Therapy in Pituitary Tumors
por: Auriemma, Renata S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_31gevn5dls2umj4fegao9irkfq